Using this cell model, we demonstrate that 7,8-DHF, quercetin, and apigenin target HSPB1, NRF2, and TRKB to reduce Tau aggregation and protect cells against Tau neurotoxicity, providing new treatment strategies for AD. This evidence concerns the gene MAPT and Alzheimer disease.